Other adverse reactions documented with metreleptin include, but are not limited to, hypersensitivity reactions (as reported for Case 10), acute pancreatitis following discontinuation of metreleptin, and hypoglycemia with concomitant use of insulin and other glucose-lowering agents (56–58). Here, INS is linked to acute pancreatitis.